A clinical case of post-COVID-19 myoendocarditis and arrhythmic syndrome at the outpatient stage

Author:

Pavlyukova Tatiana S.ORCID,Klimova Tatiana S.,Esina Elena Yu.ORCID,Lagutina Svetlana N.ORCID,Skuratova Olga S.,Zuikova Anna A.ORCID,Dobrynina Irina S.ORCID,Shevtsova Veronika I.ORCID,Chizhkov Pavel A.ORCID

Abstract

Background: Infection with the SARS-CoV-2 virus entails the development of complications which affect the prognosis of the underlying disease. More than 40% of COVID-19 complications represent diseases of the cardiovascular system, most of which are the rhythm and conduction disturbances. In order to avoid these complications, it is necessary to detect cases of infection in a timely manner at the outpatient stage. Clinical case description: A 40-year-old patient came to the clinic with complaints of interruptions in the heart rhythm that appeared after the coronavirus infection. The laboratory examination (CBC) revealed signs of systemic inflammation (leukocytosis 12.6×109 U/l; erythrocyte sedimentation rate 18 mm/h, C-reactive protein 18 mg/l); the instrumental examination of the heart revealed the rhythm disturbances in the form of frequent ventricular ectopic activity and weakness of the SA node. The patient received propafenone (150 mg, 3 times a day) as a therapy with a positive effect. Against the background of improvement in the patient’s condition and despite the history of myocarditis and a positive result of enzyme immunoassay for antibodies to SARS-CoV-2 (IgG, 10 BAU/ml), the patient was prescribed immunization with the CoviVac vaccine. After the immunization, the condition worsening was observed in the form of an increase in the rhythm disturbances, which required an inpatient treatment. A clinical diagnosis of recurrent ventricular arrhythmia — ventricular extrasystole was established, and the therapy was corrected. The outcome was favorable. Conclusion: Myocarditis is one of the most common complications of SARS-CoV-2 and should be kept in mind at all stages of medical care. This clinical case demonstrates the importance of the correct diagnosis and treatment of post-COVID myocarditis, as well as the need to assess contraindications for SARS-CoV-2 vaccination in patients with cardiac complications.

Publisher

ECO-Vector LLC

Subject

Computer Networks and Communications,Hardware and Architecture,Software

Reference10 articles.

1. Management of patients with comorbidity during novel coronavirus (COVID-19) pandemic. National Consensus Statement 2020

2. Миокардиты. Клинические рекомендации (Одобрено Научно-практическим Советом Минздрава РФ). Москва, 2020. 75 с. [Myocarditis. Clinical recommendations (Approved by the Scientific and Practical Council of the Ministry of Health of the Russian Federation). Moscow; 2020. 75 р. (In Russ).]

3. Национальный медицинский исследовательский центр кардиологии имени академика Е.И. Чазова [11 сентября 2020]. Миокардит после COVID-19: самая обсуждаемая кардиологическая проблема [интернет]. [Academician E.I. Chazov National Medical Research Center of Cardiology [September 11, 2020]. Myocarditis after COVID-19: The most discussed cardiological problem [Internet]. (In Russ).] Режим доступа: https://cardioweb.ru/news/item/2359-miokardit-posle-covid-19-samaya-obsuzhdaemaya-kardiologicheskaya-problema. Дата обращения: 15.04.2023.

4. Some Ideas how to Overcome the Post-Virus Syndrome of COVID-19

5. Infective and nonbacterial thrombotic endocarditis in patients with post-COVID-19 viral-immune myocarditis

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3